About Me
Joe Betts-LaCroix, CEO of Retro Biosciences, is dedicated to extending healthy human lifespan by ten years. A scientist-turned-entrepreneur, he began his career at Harvard, MIT, and Caltech, where his research on electron-tunneling in proteins was published in leading journals and cited over 1,500 times. A serial entrepreneur, Joe has founded multiple venture-backed startups, including OQO (acquired by Google) and Vium (acquired by Recursion Pharma), and served as a part-time partner at Y Combinator, mentoring biotech startups. At Retro, he is bringing urgency and focus to the challenge of aging, leading a team advancing novel approaches to longevity.
Hear My Insights
AI vs. Aging: The Quest for Longevity in the Age of Machine Learning
The long-held human desire to live longer is now being supercharged by artificial intelligence: scientists are leveraging machine learning to sift through massive amounts of data, pinpoint crucial biological processes, and forecast promising ways to intervene. What fresh targets and treatment approaches are emerging from AI's analytical power? How can machine learning speed up the creation and evaluation of therapies designed to slow or even reverse aging? And what are the moral and societal questions that arise as we potentially lengthen human lifespans with these advanced technologies?